Panacea Biotec Limited (NSE:PANACEABIO)
363.80
+25.65 (7.59%)
Apr 22, 2026, 3:29 PM IST
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 20.71 billion as of April 22, 2026. Its market cap has decreased by -22.97% in one year.
Market Cap
20.71B
Enterprise Value
20.05B
Revenue
6.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
363.80
Market Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has decreased from 21.08B to 20.71B, a decrease of -1.73%. That is a compound annual growth rate of -0.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 20.71B | -10.14% |
| Dec 31, 2025 | 23.05B | -10.11% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 581.08B |
| Anthem Biosciences | 406.72B |
| OneSource Specialty Pharma | 177.60B |
| Concord Biotech | 111.56B |
| Blue Jet Healthcare | 71.53B |
| Supriya Lifescience | 49.88B |
| Zota Health Care | 43.70B |
| Dishman Carbogen Amcis | 26.26B |